scholarly journals Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22‐Year Follow‐Up Study and Response to a Booster Dose

2009 ◽  
Vol 200 (9) ◽  
pp. 1390-1396 ◽  
Author(s):  
Brian J. McMahon ◽  
Catherine M. Dentinger ◽  
Dana Bruden ◽  
Carolyn Zanis ◽  
Helen Peters ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Booster Dose ◽  
Hepatitis B Vaccine ◽  
Follow Up Study ◽  
Antibody Levels

scholarly journals Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose

2016 ◽  
Vol 214 (1) ◽  
pp. 16-22 ◽  
Author(s):  
Michael G. Bruce ◽  
Dana Bruden ◽  
Debby Hurlburt ◽  
Carolyn Zanis ◽  
Gail Thompson ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Booster Dose ◽  
Hepatitis B Vaccine ◽  
Follow Up Study ◽  
Antibody Levels

scholarly journals Persistence of hepatitis B surface antibody levels after vaccination with a recombinant hepatitis B vaccine. A 3-year follow-up study.

2000 ◽  
Vol 42 (3) ◽  
pp. 147-150 ◽  
Author(s):  
Tetsunori Ozaki ◽  
Hiroshi Mochizuki ◽  
Yumiko Ichikawa ◽  
Yoichi Fukuzawa ◽  
Shigeru Yoshida ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Hepatitis B Vaccine ◽  
Recombinant Hepatitis ◽  
Follow Up Study ◽  
Antibody Levels ◽  
Surface Antibody

Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study

Vaccine ◽  
2001 ◽  
Vol 19 (28-29) ◽  
pp. 3936-3939 ◽  
Author(s):  
Zafer Kurugöl ◽  
Selda Erensoy ◽  
Sadik Akşit ◽  
Ayten Egemen ◽  
Altinay Bilgiç
Keyword(s):  
Hepatitis B ◽  
Low Dose ◽  
Hepatitis B Vaccine ◽  
Recombinant Hepatitis ◽  
Follow Up Study ◽  
Intradermal Administration

scholarly journals Long-term follow up study of anti-HBs response to human plasma derived hepatitis B vaccine and its prophylactic effect.

Kanzo ◽  
1988 ◽  
Vol 29 (7) ◽  
pp. 864-872 ◽  
Author(s):  
Kiyotsugu TAKASHIMA ◽  
Kyouichi INOUE ◽  
Kiyohiro HIGUCHI ◽  
Takehiko KONDA ◽  
Hiroshi SASAKI
Keyword(s):  
Hepatitis B ◽  
Human Plasma ◽  
Hepatitis B Vaccine ◽  
Prophylactic Effect ◽  
Follow Up Study ◽  
Long Term Follow Up

Yeast-derived hepatitis B vaccine in dental students. A three-year follow-up study

Vaccine ◽  
1990 ◽  
Vol 8 (3) ◽  
pp. 205-208 ◽  
Author(s):  
A.R. Zanetti ◽  
E. Tanzi ◽  
A. Pozzi ◽  
L. Romano ◽  
F. Bergamini
Keyword(s):  
Hepatitis B ◽  
Dental Students ◽  
Hepatitis B Vaccine ◽  
Follow Up Study

A 9-Year Follow-Up Study of the Immunogenicity and Long-Term Efficacy of Plasma-Derived Hepatitis B Vaccine in High-Risk Chinese Neonates

1993 ◽  
Vol 17 (3) ◽  
pp. 475-479 ◽  
Author(s):  
D. Lieming ◽  
Z. Mintai ◽  
W. Yinfu ◽  
Z. Shaochon ◽  
K. Weiqin ◽  
...  
Keyword(s):  
High Risk ◽  
Hepatitis B ◽  
Hepatitis B Vaccine ◽  
Follow Up Study ◽  
Term Efficacy

scholarly journals Antibody Levels in Ethiopian Children Five Years after Vaccination with Two Different Doses of Hepatitis B Vaccine: Is There a Need for Booster Vaccine?

1998 ◽  
Vol 12 (1) ◽  
pp. 57-60 ◽  
Author(s):  
Edemariam Tsega ◽  
John Horton ◽  
Erik Nordenfelt ◽  
B-J Hansson ◽  
Belachew Tafesse ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Geometric Mean ◽  
Hepatitis B Vaccine ◽  
Hbv Infection ◽  
B Virus ◽  
Antibody Titres ◽  
Antibody Levels ◽  
Surface Antibody ◽  
Different Doses

It was hypothesized that, following effective initial vaccination, a booster dose of hepatitis B vaccine will not be necessary in areas of hyperendemicity for hepatitis B virus (HBV) infection. A total of 314 Ethiopian children, ranging from two to 14 years old, were alternatively vaccinated with 10 and 20 µg hepatitis B vaccine doses, using the initial, one- and six-month schedule. Five years later, 210 of the vaccinees were retested for anti-HBV surface antibody titres. Both 10 and 20 µg doses of hepatitis B rDNA yeast vaccine were equally immunogenic and protective against HBV infection for at least five years despite marked reduction of mean antibody levels and geometric mean titres, with 11% of the vaccinees showing antibodies below the protective level. For firm further recommendations a longer follow-up period of vaccinees is suggested.

Sign in / Sign up

Export Citation Format

Share Document